OBJECTIVE -To compare regional body fat distribution and sex hormone status of postmenopausal women with NIDDM with those of age-and BMI-matched normoglycemic women.
I
n healthy premenopausal women, body fat is deposited primarily on the lower body, with fat accumulating on the hips and thighs (a gynoid pattern), whereas men accumulate abdominal fat (an android pattern) (1) . After menopause (1) or in the presence of NIDDM (2) , women show an increase in the abdominal fat deposits more characteristic of men. Accumulation of abdominal fat, particularly intra-abdominal adipose tissue (IAAT), is associated with dyslipidemia and aberrations in glucoseinsulin homeostasis (3) and is an important risk factor for NIDDM and coronary heart disease (CHD) (3) . In addition, android obesity in both postmenopausal women (4) and women with NIDDM (5) is associated with increasing androgenicity, as reflected by decreased sex hormone-binding globulin (SHBG) and increased free testosterone. While android obesity is clearly an important characteristic of women with NIDDM, little attention has focused on the relative partitioning of body fat between upper and lower body segments in these women. In this study, we examined this issue by comparing body fat distributions and sex hormone profiles of postmenopausal women with NIDDM with those of normoglycemic women matched for both age and BMI.
RESEARCH DESIGN AND

M E T H O D S -Postmenopausal
Australian-born women (42 with and 42 without NIDDM) of predominantly AngloCeltic origin were recruited for the present study from the enrolled participants of the prospective community-based Melbourne Collaborative Cohort Study (MCCS) (6) . The participation response rate was 76%. Diabetic subjects were recruited in descending order of age on a quota-filling basis from a sequential list of Australian-born women who reported a history of diabetes. Diabetic status was confirmed either from their current medical treatment or after administration of a 75-g oral glucose tolerance test (OGTT) and classification according to World Health Organization guidelines (7) . Nondiabetic control subjects, who were selected to match NIDDM subjects for age and BMI, were classified as normoglycemic after an OGTT. Of the 42 women with confirmed NIDDM, 16 were controlled by diet therapy alone, 25 received oral hypoglycemic medication, and one received insulin therapy They were aged 64 ± 1 years and were 17 ± 1 years past menopause (YPM). Their diabetes had been diagnosed for 7 ± 1 years, and they had HbA lc levels of 7.3 ± 2.0%. Fourteen of these women were past or current users of hormone-replacement therapy (HRT). Control subjects were aged 63 ± 1 years and were 14 ± 1 YPM, and 16 of these women were past or current users of HRT. The study was approved by the ethics committees of St. Vincent's Hospital and Deakin University in Melbourne, Australia.
In each subject, body weight, height, waist and hip circumferences, and sagittal height were measured (8) , and dual-energy X-ray absorptiometry (DEXA) (DPX-L; Lunar Corporation, Madison, WI) was used to perform a total body scan. Total fat Data are means ± SEM or geometric mean (95% CI). * Significantly different from NIDDM group, P < 0.01; tsignificantly different from NIDDM group, P < 0.001; ^significantly different from NIDDM group, P < 0.05.
mass (FM), lean tissue mass (LTM), upperbody fat (UBF), and lower-body fat (LBF)
were determined (8) . In addition, fat content was quantified in two regions of interest (ROIs), the android waist and the gynoid thigh, denned manually (1). The coefficients of variation (CVs) were 3.2, 1.5, 4.3, 3.1, 5.1, and 3.4% for FM, LTM, UBF, LBF, android waist fat, and gynoid thigh fat, respectively. 1AAT was calculated using the anthropometric DEXA equation of Treuth and coworkers (9) . A fasting blood sample was also collected from each subject. Serum testosterone and SHBG (Orion Diagnostica, Espoo, Finland) were measured by radioimmunoassay (interassay CV 2.7% and 3.9% respectively). The free androgen index (FAI) was calculated as the ratio of testosterone to SHBG multiplied by 100. All values are expressed as means ± SEM, with the exception of SHBG and testosterone, which are given as geometric means (95% CI) after logarithmic transformation. Statistical analyses were performed using SPSS for Windows, version 6.0 (SPSS, Chicago). Comparisons between NIDDM and control subjects were made by two-tailed, unpaired Students t test. Regression analysis was used to compare levels of gynoid thigh fat in NIDDM and control groups after adjusting for total fat. Interaction effects were also tested. In addition,
Pearsons correlation coefficient was used to assess the association between android waist fat and the FAI in NIDDM and control subjects, and regression analysis was used to determine whether these associations differed between the groups. P < 0.05 was considered to be significant.
RESULTS-The anthropometric characteristics, body composition, and regional fat distribution by DEXA of the communityrecruited groups examined in this study are presented in Table 1 . The women with NIDDM had a significantly higher waist circumference and waist-to-hip ratio than normoglycemic women matched for age and BMI (P < 0.01 and P < 0.001, respectively). The NIDDM and control groups had similar total FM, LTM, and UBF, although the NIDDM group had higher calculated levels of IAAT (153 ± 5 vs. 132 ± 5 cm 2 , P < 0.01). Interestingly, the aormoglycemie women had more LBF than the women with NIDDM (P < 0.01). Thus, women with NIDDM had a higher ratio of UBF to LBF (P < 0.001). Compared with women with NIDDM, normoglycemic women had similar fat deposition in the android waist ROI but higher fat deposition in the gynoid thigh ROI (P < 0.001). Further regression analysis confirmed that for a given level of total body fat, the mean level of thigh fat for the NIDDM group was significantly less than that of the control subjects, because the intercepts for the two regressions were significantly different (P < 0.001) (Fig. 1) .
This differing pattern of fat deposition was accompanied by differences in sex hormones (Table 1) . Relative to the normoglycemic control women, women with NIDDM had higher levels of serum testosterone (P < 0.1), lower levels of SHBG (P < 0.05), and therefore a lower FAI (P < 0.01). In normoglycemic women, the FAI was strongly related to the level of fat in the android waist ROI (r = 0.63, P < 0.001), but in women with NIDDM, this relationship was not evident (r = -0.08). Regression analysis of the association between android waist fat and FAI indicated that the Total Fat (kg) DIABETES CARE, VOLUME 21, NUMBER 5, MAY 1998
Relative reduction in lower-body fat in women with NIDDM slopes of these two regression lines were significantly different (P < 0.001).
CONCLUSIONS-The major observation in the present study was that women with NIDDM had a smaller relative accumulation of LBF than normoglycemic control subjects of similar total FM. An androgenic hormone profile, characterized by lower levels of SHBG and an increased FAI, accompanied this pattern of fat deposition in postmenopausal women with NIDDM.
Subjects for the present study were recruited from the MCCS (6), which provided the opportunity to study women from the wider community who were not selected for NIDDM, because diabetes was not a focus of selection for the MCCS. This method of selecting study participants strengthens the findings by limiting the potential confounding effect of referral selection bias, which is likely to have occurred had the women been selected from a diabetes clinic (10) . The representativeness of the diabetic women in the present study is further supported by the documented prevalence of self-reported diabetes in 45-to 69-year-old Anglo-Celtic women recruited into the MCCS (2.24%) (G.G.G., unpublished observations) and the prevalence of self-reported diabetes in 45-to 64-year-old women (2.3%) in a population-based survey conducted in Busselton, Western Australia (11) .
The women with NIDDM were clearly shown to have an androgenic hormone profile, a finding in agreement with previous studies (5, 12) . A strong relationship between the FAI and the android waist fat was found in the control subjects, which corresponds with other studies documented in the literature (3). Because this association was no longer evident in women with NIDDM, however, it is possible that elevation of the FAI observed in NIDDM is less influenced by android fat deposition than by the diabetic state itself.
Although it is well established that abdominal adiposity is strongly related to the development of the insulin resistance syndrome and to the risk of NIDDM and CHD (3), little is known of the role of fat deposition at other sites, particularly LBF or femoral fat. The possible clinical significance of our finding that women with NIDDM have reduced levels of LBF, is suggested by recent cross-sectional studies indicating that increased leg fat (13) or FM in the thigh (14) is associated with favorable changes in the lipid profile of overweight women. In addition, a recent case-control study has shown that increased thigh circumference confers protection against ischemic heart disease in both men and women (15) . A reduced capacity to deposit and/or conserve LBF may thus predispose women with NIDDM to increased cardiovascular risk in addition to the risks posed by accumulation of IAAT (3) . The possibility that the smaller relative accumulation of LBF in postmenopausal women with NIDDM is a consequence of the androgenic hormonal profile should be investigated in future studies.
